EmsanaRx, the upstart pharmacy benefit manager (PBM) that says its priority is public health, announced yesterday that it is changing its name to AffirmedRx.
EmsanaRx was launched in late 2021 as project of Emsana Health, an independent company established by The Purchaser Business Group on Health, a coalition of large employers. Emsana Health bills itself as an “innovation studio” for healthcare.
According to a press release Emsana Health sold its equity stake back EmsanaRx.
The press release says that AffirmedRx will continue EmsanaRx’s work “to create a completely unconflicted pharmacy benefit manager that all large self-funded employers can be proud to collaborate with.”
Greg Baker, CEO of EmsanaRx, is staying CEO of AffirmedRx, which has adopted “patients over profits” as it tagline. Like EmsanaRx, AffirmedRex is a public benefit corporation, a legal status that allows the company to prioritize public good and not just shareholders.
Baker says in the new name reflects “our commitment to forging new paths with members to deliver innovation and flexibility.”
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen